Cargando...
Directed evolution of CRISPR-Cas9 to increase its specificity
The use of CRISPR-Cas9 as a therapeutic reagent is hampered by its off-target effects. Although rationally designed S. pyogenes Cas9 (SpCas9) variants that display higher specificities than the wild-type SpCas9 protein are available, these attenuated Cas9 variants are often poorly efficient in human...
Guardado en:
| Publicado en: | Nat Commun |
|---|---|
| Autores principales: | , , , , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Nature Publishing Group UK
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6078992/ https://ncbi.nlm.nih.gov/pubmed/30082838 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41467-018-05477-x |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|